Royalty Pharma
RPRX
#623
Rank
NZ$71.92 B
Marketcap
NZ$125.10
Share price
-0.01%
Change (1 day)
79.41%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2026 (TTM): NZ$2.69 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are NZ$2.61 Billion. In 2025 the company made an earning of NZ$2.97 Billion, an increase over its 2024 earnings that were of NZ$2.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$2.69 B-9.26%
2025 NZ$2.97 B4.79%
2024 NZ$2.83 B-17.54%
2023 NZ$3.43 B351.47%
2022 NZ$0.76 B-70.3%
2021 NZ$2.56 B-24.3%
2020 NZ$3.38 B-31.9%
2019 NZ$4.97 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$13.14 B 367.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.33 B 2,151.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$0.28 B-89.78%๐Ÿ‡บ๐Ÿ‡ธ USA